Matrixx Initiatives Inc Recalls

FDA
1
Total Recalls
1
Agencies
Feb 2013
First Recall
Feb 2013
Latest Recall

Showing 1-1 of 1 recalls

FDA

Zicam Extreme Congestion Relief (oxymetazoline HCl) nasal gel, 0.05%, 0.50 fl. oz. (15 mL) spray bottle, Developed and distributed by Zicam LLC, Scottsdale, Arizona 85255, a wholly owned subsidiary of Matrixx Initiatives Inc, NDC 62750-005-10, UPC 7 32216 20410 0.

Microbial Contamination of Non-Sterile Products: Product may be contaminated with Burkholderia cepacia.